Ozone infiltration as an adjunctive treatment to piezoelectric surgery in the management of medication-related osteonecrosis of the jaws: case series of 29 patients

被引:1
作者
Goker, Funda [1 ,2 ]
Donati, Girolamo [3 ]
Gallo, Francesco
Sparaco, Antonella [3 ]
Rania, Vito [3 ]
Busa, Alberto [3 ]
Grecchi, Francesco [4 ,5 ]
Grecchi, Emma [5 ]
Colapinto, Gianluca [6 ]
Del Fabbro, Massimo [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, MI, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy
[3] ASST Fatebenefratelli Sacco Hosp, Dent Dept, Via Giovanni Battista Grassi 74, Milan, Italy
[4] Ist Stomatol Italiano Milano, Via Pace 21, I-20122 Milan, Italy
[5] Via G Boccaccio 34, I-20123 Milan, Italy
[6] Oral Med Care Srl, Bitonto, Bari, Italy
来源
ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG | 2024年 / 28卷 / 03期
关键词
MRONJ; MRONJ treatment; Ozone therapy; Piezoelectric surgery; Oxygen therapy; BISPHOSPHONATE-RELATED OSTEONECROSIS; THERAPY; BRONJ;
D O I
10.1007/s10006-024-01246-x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
PurposeMedication-related osteonecrosis of the jaws has been reported to be associated with bisphosphonate and RANKL inhibitor medications. This prospective clinical study aimed to assess the outcomes of pre-operative ozone infiltration therapy in patients with established MRONJ.MethodsThe treatment protocol for ozone applications were designed as 20 applications ozone infiltration therapy followed by surgical interventions of necrotic tissue debridement using piezoelectric surgery instruments. The evaluation of the results based on the clinical and radiologic specifications considering the necrotic lesion reduction and healing. The study included 31 lesions in 29 patients. The mean follow-up was 23.6 months.Results25 lesions out of 31 healed totally without any remissions. The outcomes were not affected by any variables such as gender, age, type of pharmacological treatment, lesion location, and MRONJ staging. The statistically significant results were found among the clinical condition of the patients (p = 0.01) and administration route of medications (p = 0.004). Healing was significantly less in patients that received intra-vascular administrations. Clinical conditions of the patients were divided as osteoporosis, oncologic, and arthritis. Significantly better results were obtained in osteoporosis patients. 38% of the population experienced spontaneous sequestration with signs of improvements and the surgical interventions were canceled. According to the results, total healing of MRONJ lesions was seen in 79% patients (81% lesions).ConclusionOzone therapy and debridement with Piezoelectric surgery can be considered as a safe and beneficial adjunctive treatment alternative for osteonecrosis lesions in cases of established MRONJ.
引用
收藏
页码:1197 / 1207
页数:11
相关论文
共 30 条
  • [21] Olate S, 2014, INT J CLIN EXP MED, V7, P3707
  • [22] Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
    Otto, Sven
    Aljohani, Suad
    Fliefel, Riham
    Ecke, Sara
    Ristow, Oliver
    Burian, Egon
    Troeltzsch, Matthias
    Pautke, Christoph
    Ehrenfeld, Michael
    [J]. MEDICINA-LITHUANIA, 2021, 57 (05):
  • [23] Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
    Otto, Sven
    Pautke, Christoph
    Van den Wyngaert, Tim
    Niepel, Daniela
    Schiodt, Morten
    [J]. CANCER TREATMENT REVIEWS, 2018, 69 : 177 - 187
  • [24] Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients
    Petrucci, Maria Teresa
    Gallucci, Cristiano
    Agrillo, Alessandro
    Mustazza, Maria Cristina
    Foa, Robin
    [J]. HAEMATOLOGICA, 2007, 92 (09) : 1289 - 1290
  • [25] Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review
    Raimondi, Alessandra
    Simeone, Noemi
    Guzzo, Marco
    Maniezzo, Massimo
    Collini, Paola
    Morosi, Carlo
    Greco, Francesca Gabriella
    Frezza, Anna Maria
    Casali, Paolo G.
    Stacchiotti, Silvia
    [J]. ESMO OPEN, 2020, 5 (04)
  • [26] New Non-isphosphonate Drugs That Produce Osteonecrosis of the Jaws
    Ramirez, Lucia
    Maria Lopez-Pintor, Rosa
    Casanas, Elisabeth
    de Arriba, Lorenzo
    Hernandez, Gonzalo
    [J]. ORAL HEALTH & PREVENTIVE DENTISTRY, 2015, 13 (05) : 385 - 393
  • [27] Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study
    Ripamonti, Carla Ida
    Cislaghi, Enrico
    Mariani, Luigi
    Maniezzo, Massimo
    [J]. ORAL ONCOLOGY, 2011, 47 (03) : 185 - 190
  • [28] American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update
    Ruggiero, Salvatore L.
    Dodson, Thomas B.
    Aghaloo, Tara
    Carlson, Eric R.
    Ward, Brent B.
    Kademani, Deepak
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2022, 80 (05) : 920 - 943
  • [29] Osteonecrosis of the mandible associated with bevacizumab therapy
    Santos-Silva, Alan Roger
    Belizario Rosa, Giuliano Augusto
    de Castro Junior, Gilberto
    Dias, Reinaldo Brito
    Prado Ribeiro, Ana Carolina
    Brandao, Thais Bianca
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 115 (06): : E32 - E36
  • [30] Clinical utility of ozone therapy for musculoskeletal disorders
    Seyam, Omar
    Smith, Noel L.
    Reid, Inefta
    Gandhi, Jason
    Jiang, Wendy
    Khan, Sardar Ali
    [J]. MEDICAL GAS RESEARCH, 2018, 8 (03): : 103 - 110